Is it Worth Investing in Exponent (EXPO)?

Harding Loevner, an investment management firm, published its “Global Small Companies Equity Fund” third-quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly net return of 1.94% was recorded by the fund for the third quarter of 2021, beating its Benchmark, the MSCI All Country World Small Cap Index, which returned -1.42 % for the same period. You can take a look at the fund’s top 5 holdings to have an idea about their best picks for 2021.

Harding Loevner Global Small Companies Equity Fund, in its Q3 2021 investor letter, mentioned Exponent, Inc. (NASDAQ: EXPO) and discussed its stance on the firm. Exponent, Inc. is a Menlo Park, California-based research company with a $6.2 billion market capitalization. EXPO delivered a 31.53% return since the beginning of the year, while its 12-month returns are up by 42.50%. The stock closed at $118.42 per share on December 03, 2021.

Here is what Harding Loevner Global Small Companies Equity Fund has to say about Exponent, Inc.  in its Q3 2021 investor letter:

“Similar dynamics are playing out in the service sectors, where the tight labor market is causing consulting services companies to mull their own price hikes. US-based science and engineering consulting firm Exponent reported a strong quarter due to both high utilization of its services and rate increases of 7%, enough to compensate for the wage inflation it is experiencing.”

Based on our calculations, Exponent, Inc. (NASDAQ: EXPO) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. EXPO was in 21 hedge fund portfolios at the end of the third quarter of 2021, compared to 20 funds in the previous quarter. Exponent, Inc. (NASDAQ: EXPO) delivered a 1.27% return in the past 3 months.

Disclosure: None. This article is originally published at Insider Monkey.